Healthtech Wearables Intelligence Report covering 257 devices across 17 categories | Healthcare Discovery
| | |

NeuroSky MindWave Mobile 2: The Most Affordable Consumer EEG for Beginners and Developers

A single channel EEG headset that costs less than a fitness tracker, offering the lowest barrier to entry for anyone curious about brainwave monitoring, neurofeedback, and brain computer interface development….

Healthtech Wearables Intelligence Report covering 257 devices across 17 categories | Healthcare Discovery
| | |

Emotiv EPOC X: 14 Channel Research Grade EEG for Brain Mapping and Cognitive Science

The most channel dense consumer EEG headset available, offering 14 sensors that approach the spatial resolution of clinical brain monitoring systems at a fraction of the cost and complexity. When…

Healthtech Wearables Intelligence Report covering 257 devices across 17 categories | Healthcare Discovery
| | |

Muse 2 EEG Headband: Brain Sensing Technology for Meditation and Focus Training

A consumer EEG headband that translates your brainwave activity into real time audio feedback, turning meditation from a subjective practice into a measurable skill. Most people who try meditation quit…

Healthcare Discovery NAD+ brain aging sleep neurodegeneration research 2026 showing cellular fuel powering neurons and mitochondria
| | |

The NAD+ Renaissance: How a Cellular Fuel Molecule Is Rewriting the Science of Brain Aging, Sleep, and Neurodegeneration

A landmark Nature Aging expert review by 25 scientists, a Science Advances study showing NAD+ reverses Alzheimer’s memory deficits through RNA splicing, and the first human evidence that oral NAD+…

Healthcare Discovery Alzheimer's blood test image showing p-tau217 biomarkers, finger prick diagnostics, lithium science, and cognitive aging
| | |

Blood Tests Are Rewriting Alzheimer’s Detection: How P-Tau217, Finger Prick Diagnostics, and Lithium Science Are Transforming Cognitive Aging

A convergence of 2026 studies in Nature Medicine and Nature Aging is transforming Alzheimer’s detection. The p-tau217 blood test clock predicts symptom onset within three to four years, a finger…

The Daily Rounds: Longevity & Health Care Brief | April 5, 2026
| | | |

The Daily Rounds: Longevity & Health Care Brief | April 5, 2026

🧬 Cellular Reprogramming Enters Human Trials — Life Biosciences has launched the first FDA-approved partial de-aging trial, translating Sinclair's epigenetic reprogramming research from animal models to human medicine. 🧠 Gut-Brain Axis Reverses Memory Loss — Stanford's Nature study shows that correcting age-related gut bacteria shifts restores youthful cognitive performance by reactivating vagus nerve signaling to the hippocampus. 🤖 AI Drug Discovery Reaches Clinical Scale — 173+ AI-designed drug candidates are now in clinical trials, and longevity medicine is being advised to prepare for AI therapeutics to arrive in clinical practice imminently. 🦠 Gut Microbiome as Active Immune Regulator — New research reveals gut bacteria actively inject proteins into cells to modulate immunity, and a microbiome-derived molecule doubled lung cancer immunotherapy response rates in mice. 😴 Circadian Fragmentation Doubles Dementia Risk — A large Neurology journal study found that weak or late-peaking daily activity rhythms more than double the risk of dementia, making circadian optimization a key prevention target.

Alzheimer's blood-brain barrier nanoparticle research | Healthcare Discovery
| | |

Resistance Training Is Medicine for Your Brain: What 2026 Research Reveals About Strength Training, Depression, and Cognitive Decline

A growing body of clinical evidence shows that resistance training reduces depression symptoms as effectively as frontline medications, slows cognitive decline in aging adults, and triggers neurobiological changes that no…

Consistent sleep-wake rhythm aligning brain, heart, and metabolic signals for longevity
| | |

Sleep Regularity May Matter More Than Sleep Duration for How Long You Live: What 60,977 People and Three Landmark Studies Reveal About the Dimension of Sleep Most People Ignore

A landmark UK Biobank study of 60,977 people found that sleep regularity is a stronger predictor of mortality than sleep duration, reducing all-cause death risk by 30 percent. Combined with…

Healthcare Discovery GLP-1 drugs Alzheimer brain EVOKE trial neurodegeneration 2026 showing metabolic signals and brain biomarkers
| | |

GLP-1 Drugs and the Brain: Why the Biggest Alzheimer’s Trial Failed but the Science Is Far From Over

The EVOKE and EVOKE+ trials of oral semaglutide in 3,808 Alzheimer’s patients failed their primary endpoints, but stunning biomarker data, positive liraglutide brain volume results, and consistent real-world evidence from…